Perspective Therapeutics (CATX) Receivables (2011 - 2026)
Perspective Therapeutics recorded quarterly Receivables of $58000.0 in Q1 2026, up 262.5% quarter-over-quarter from $16000.0 in Q4 2025, and down 25.64% year-over-year from $78000.0 in Q1 2025.
Perspective Therapeutics' Receivables history runs 16 years deep, the most recent figure standing at $58000.0 for Q1 2026.
- In Q1 2026, Receivables fell 25.64% year-over-year to $58000.0; the TTM figure through Mar 2026 stood at $58000.0 (down 25.64% YoY), while the FY2025 annual figure was $16000.0, down 97.35% from the prior year.
- Receivables came in at $58000.0 for Q1 2026 at Perspective Therapeutics, up from $16000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $2.1 million in Q1 2022 to a low of $16000.0 in Q4 2025.
- A 5-year average of $837823.5 and a median of $999000.0 in 2024 frame the typical range for Receivables.
- On a YoY basis, Receivables climbed as much as 58.45% in 2025 and fell as far as 97.35% in 2025.
- Perspective Therapeutics' Receivables stood at $1.4 million in 2022, then declined by 13.92% to $1.2 million in 2023, then tumbled by 48.68% to $603000.0 in 2024, then sank by 97.35% to $16000.0 in 2025, then surged by 262.5% to $58000.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $58000.0, $16000.0, and $179000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.09 Bn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 58,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 78,000.00 |
| Dec 31, 2024 | 603,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 999,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 1.90 Mn |
| Jun 30, 2021 | 2.05 Mn |
| Mar 31, 2021 | 2.02 Mn |
| Dec 31, 2020 | 1.74 Mn |
| Sep 30, 2020 | 1.76 Mn |
| Jun 30, 2020 | 2.08 Mn |
| Mar 31, 2020 | 2.15 Mn |
| Dec 31, 2019 | 1.41 Mn |
| Sep 30, 2019 | 1.52 Mn |
| Jun 30, 2019 | 1.24 Mn |
| Mar 31, 2019 | 1.12 Mn |
| Dec 31, 2018 | 1.11 Mn |
| Sep 30, 2018 | 1.07 Mn |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 970,000.00 |
| Dec 31, 2017 | 987,000.00 |
| Sep 30, 2017 | 743,000.00 |
| Jun 30, 2017 | 793,000.00 |
| Mar 31, 2017 | 854,000.00 |
| Dec 31, 2016 | 627,000.00 |
| Sep 30, 2016 | 574,000.00 |
| Jun 30, 2016 | 605,108.00 |
| Mar 31, 2016 | 888,800.00 |
| Dec 31, 2015 | 984,057.00 |
| Sep 30, 2015 | 1.14 Mn |
| Jun 30, 2015 | 1.07 Mn |
| Mar 31, 2015 | 1.05 Mn |
| Dec 31, 2014 | 808,359.00 |
| Sep 30, 2014 | 967,517.00 |
| Jun 30, 2014 | 966,131.00 |
| Mar 31, 2014 | 805,326.00 |
| Dec 31, 2013 | 927,286.00 |
| Sep 30, 2013 | 971,549.00 |
| Jun 30, 2013 | 935,282.00 |
| Mar 31, 2013 | 837,756.00 |
| Dec 31, 2012 | 664,179.00 |
| Sep 30, 2012 | 856,238.00 |
| Jun 30, 2012 | 874,981.00 |
| Mar 31, 2012 | 872,572.00 |
| Dec 31, 2011 | 849,478.00 |
| Sep 30, 2011 | 991,793.00 |
| Jun 30, 2011 | 1.22 Mn |